Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Buchler

Showing results (251-260 of 502) with videos related to

Pageof 51
Sort By:
BMJ Open|September 20, 2023
Protocol of a randomised controlled phase II clinical trial investigating PREoperative endoscopic injection of BOTulinum toxin into the sphincter of Oddi to reduce bile leakage after hepatic resection: the PREBOT-II trialClaudia Eva Mack, Ulla Klaiber, Peter Sauer, et al.
Urologic Oncology|March 18, 2014
Efficacy of everolimus in second- and third-line therapy for metastatic renal cell carcinoma: a registry-based analysisTomas Buchler, Zbynek Bortlicek, Alexandr Poprach, et al.
Optics Express|June 12, 2008
Delay of squeezing and entanglement using electromagnetically induced transparency in a vapour cellG Hètet, B C Buchler, O Glöeckl, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
High dose rate intracavitary brachytherapy for carcinoma of the cervix: the Madison system: II. Procedural and physical considerationsB R Thomadsen, S Shahabi, J A Stitt, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|February 5, 2005
Outcome of patients with multiple myeloma and hypertension treated with angiotensin-I-converting enzyme inhibitors during high-dose chemotherapyTomas Buchler, Marta Krejci, Adam Svobodnik, et al.
Journal of Cancer|December 7, 2018
The Association of Baseline Serum Tumour Markers with Outcome of Patients with Metastatic Colorectal Cancer Treated with Anti-EGFR Monoclonal Antibodies in the First LineOndrej Fiala, Petr Hosek, Ondrej Sorejs, et al.
Advances in Therapy|January 29, 2019
Prospective Observational Cohort Study to Describe the Use of Panitumumab in Combination with Chemotherapy in Real-World Clinical Practice for Patients with Wild-Type RAS mCRCHolger Hebart, Michael Kiehl, Jiri Tomasek, et al.
Annals of Transplantation|April 29, 2016
Dosing of Enteric-Coated Mycophenolate Sodium Under Routine Conditions: An Observational, Multicenter Study in Kidney TransplantationLaetitia Albano, Matthias Buchler, Diego Cantarovich, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 20, 2015
High serum level of C-reactive protein is associated with worse outcome of patients with advanced-stage NSCLC treated with erlotinibOndrej Fiala, Milos Pesek, Jindrich Finek, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1995
Impact of "optimized" treatment planning for tandem and ring, and tandem and ovoids, using high dose rate brachytherapy for cervical cancerW R Noyes, N E Peters, B R Thomadsen, et al.
Pageof 51

Showing results (251-260 of 502) with videos related to

Sort By:
Pageof 51
BMJ Open|September 20, 2023
Protocol of a randomised controlled phase II clinical trial investigating PREoperative endoscopic injection of BOTulinum toxin into the sphincter of Oddi to reduce bile leakage after hepatic resection: the PREBOT-II trialClaudia Eva Mack, Ulla Klaiber, Peter Sauer, et al.
Urologic Oncology|March 18, 2014
Efficacy of everolimus in second- and third-line therapy for metastatic renal cell carcinoma: a registry-based analysisTomas Buchler, Zbynek Bortlicek, Alexandr Poprach, et al.
Optics Express|June 12, 2008
Delay of squeezing and entanglement using electromagnetically induced transparency in a vapour cellG Hètet, B C Buchler, O Glöeckl, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
High dose rate intracavitary brachytherapy for carcinoma of the cervix: the Madison system: II. Procedural and physical considerationsB R Thomadsen, S Shahabi, J A Stitt, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|February 5, 2005
Outcome of patients with multiple myeloma and hypertension treated with angiotensin-I-converting enzyme inhibitors during high-dose chemotherapyTomas Buchler, Marta Krejci, Adam Svobodnik, et al.
Journal of Cancer|December 7, 2018
The Association of Baseline Serum Tumour Markers with Outcome of Patients with Metastatic Colorectal Cancer Treated with Anti-EGFR Monoclonal Antibodies in the First LineOndrej Fiala, Petr Hosek, Ondrej Sorejs, et al.
Advances in Therapy|January 29, 2019
Prospective Observational Cohort Study to Describe the Use of Panitumumab in Combination with Chemotherapy in Real-World Clinical Practice for Patients with Wild-Type RAS mCRCHolger Hebart, Michael Kiehl, Jiri Tomasek, et al.
Annals of Transplantation|April 29, 2016
Dosing of Enteric-Coated Mycophenolate Sodium Under Routine Conditions: An Observational, Multicenter Study in Kidney TransplantationLaetitia Albano, Matthias Buchler, Diego Cantarovich, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 20, 2015
High serum level of C-reactive protein is associated with worse outcome of patients with advanced-stage NSCLC treated with erlotinibOndrej Fiala, Milos Pesek, Jindrich Finek, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1995
Impact of "optimized" treatment planning for tandem and ring, and tandem and ovoids, using high dose rate brachytherapy for cervical cancerW R Noyes, N E Peters, B R Thomadsen, et al.
Pageof 51